Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04383132
Other study ID # Beslen-korse
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 15, 2020
Est. completion date August 15, 2020

Study information

Verified date October 2020
Source Martyr Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Colonoscopy is considered the primary screening test for colorectal cancer screening worldwide. For technical difficulties previously experienced during colonoscopy, especially loop of the colonoscopy device in the colon, many solution methods have been developed and applied (manual pressure and position change, etc.). Although these methods are partially successful, there is no consensus on the optimum solution method. Few studies in the literature have investigated the use of corset during colonoscopy and conflicting results have been reported. In this study, elastic abdominal corset or false corset will be used during colonoscopy. Indeed, the investigators aim to determine whether this method is effective and safe with their own results and contribute to the literature. The primary outcome of this study will be the cecal intubation time. Secondary outcomes include manual pressure and position change during the procedure, length of cecal intubation (length of colonoscope required to reach the cecum from the anus), colonoscopy completion rate, additional anesthesia and / or analgesic requirement, patient pain and comfort level and colonoscopic findings.Efficacy will be assessed on the basis of pairwise comparisons between groups with respect to primary and secondary outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 346
Est. completion date August 15, 2020
Est. primary completion date August 15, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: Between the ages of 18 - 90 Participants must have completed the full prescribed colonoscopy purgative preparation prior to their procedure, and describe adequate cleansing. Participants with ASA I-III (American Society of Anesthesiologists Class III) Exclusion Criteria: Previous colon resection History of intra-abdominal malignancy Known anesthetic or analgesic drugs allergy Multiple planned procedures (e.g.bidirectional endoscopy) Pregnancy Active inflammatory bowel disease A history of intraabdominal malignancy History of cirrhosis or ascites Known ventral hernia

Study Design


Related Conditions & MeSH terms

  • Performance and Tolerance of Colonoscopy

Intervention

Device:
Abdominal Binder
abdominal binder is a kind of elastic abdominal compression device

Locations

Country Name City State
Turkey Martyr Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Martyr Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Cecal Intubation Time Cecal intubation time will be defined as the time from insertion of the colonoscope into the rectum to identification of the base of the cecum During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified,an average of 1-30 minutes
Secondary Number of Participants Who Required Ancillary Maneuvers Binary data indicating individually whether abdominal pressure or patient position change was used during the insertion phase of the procedure will be recorded. During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified, an average of 1-30 minutes
Secondary Length of Cecal Intubation The length of the colonoscope required to reach the cecum from the anus will be measured From inserting the scope into the rectum during the colonoscopy, until the cecum base is determined, an average of 1-30 minutes
Secondary Number of Participants Who Completed the Procedure Dichotomous outcome indicating if the procedure was incomplete or complete. During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum,an average of 2-60 minutes
Secondary Number of Participants Who Required Additional Anesthetic and / or Analgesic Drug Whether the patient needs an additional dose of anesthetic and / or analgesic drug to complete the colonoscopy During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum,an average of 2-60 minutes
Secondary Patient Pain and Comfort Level at Discharge Study assistant will interview patient just prior to discharge and obtain responses for pain according to 10-point visual analog scales ( scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" =1 (min) and "worst pain"=10 (max)) and global satisfaction according to a 5-point scale ( scores are recorded by making a handwritten mark on a 5-cm line that represents a continuum between "very unsatisfied" =1 (min) and "very satisfied"=5 (max) ) At single time point occurring after the colonoscopy, just prior to the patient being discharged from facility,an average of 60 minutes
Secondary Number of Participants According to Colonoscopy Findings Findings such as polyp, cancer, diverticulum detected during colonoscopy will be recorded. During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum,an average of 2-60 minutes
See also
  Status Clinical Trial Phase
Completed NCT02025504 - Carolina-ColoWrap® in Colonoscopy Performance and Outcomes Study N/A